{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-010063","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2024-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.195858+00:00","generated_at":"2026-06-06T09:58:33.406531+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Elutia reprices stock options and grants new equity to CEO, CFO, CSO, and other employees","bullets":["CEO C. Randal Mills' existing options and RSUs vesting thresholds lowered to $6, $10, $14, $18 per share.","CEO granted 650,000 options and 650,000 RSUs; CFO and CSO each granted 200,000 options and 200,000 RSUs.","Non-executive employee options repriced from >$7 to $3.61 per share, covering 144,427 shares.","New equity grants to other employees include 565,561 options and 1,167,500 RSUs.","Vesting of some awards contingent on FDA clearance of CanGarooRM antibiotic-eluting envelope."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-010063","json":"https://secwatch.observer/filing/0001104659-24-010063.json","markdown":"https://secwatch.observer/filing/0001104659-24-010063.md","text":"https://secwatch.observer/filing/0001104659-24-010063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465924010063/0001104659-24-010063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465924010063/tm244998d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T09:58:33.406531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}